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Trauma-related emotions and radical
acceptance in dialectical behavior therapy
for posttraumatic stress disorder after
childhood sexual abuse
Nora Görg1,2* , Kathlen Priebe1,2, Jan R. Böhnke3, Regina Steil4, Anne S. Dyer2,5 and Nikolaus Kleindienst1,2
Abstract
Background: Posttraumatic Stress Disorder (PTSD) related to childhood sexual abuse (CSA) is often associated with
a wide range of trauma-related aversive emotions such as fear, disgust, sadness, shame, guilt, and anger. Intense
experience of aversive emotions in particular has been linked to higher psychopathology in trauma survivors. Most
established psychosocial treatments aim to reduce avoidance of trauma-related memories and associated emotions.
Interventions based on Dialectical Behavior Therapy (DBT) also foster radical acceptance of the traumatic event.
Methods: This study compares individual ratings of trauma-related emotions and radical acceptance between the
start and the end of DBT for PTSD (DBT-PTSD) related to CSA. We expected a decrease in trauma-related emotions
and an increase in acceptance. In addition, we tested whether therapy response according to the Clinician
Administered PTSD-Scale (CAPS) for the DSM-IV was associated with changes in trauma-related emotions and
acceptance. The data was collected within a randomized controlled trial testing the efficacy of DBT-PTSD, and a
subsample of 23 women was included in this secondary data analysis.
Results: In a multilevel model, shame, guilt, disgust, distress, and fear decreased significantly from the start to the
end of the therapy whereas radical acceptance increased. Therapy response measured with the CAPS was
associated with change in trauma-related emotions.
Conclusions: Trauma-related emotions and radical acceptance showed significant changes from the start to the
end of DBT-PTSD. Future studies with larger sample sizes and control group designs are needed to test whether
these changes are due to the treatment.
Trial registration: ClinicalTrials.gov, number NCT00481000
Keywords: Posttraumatic stress disorder, Exposure therapy, Dialectical behavior therapy
Background
Patients with Posttraumatic Stress Disorder (PTSD)
typically report a wide range of aversive emotions (e. g.,
fear, disgust, sadness, shame, guilt, and anger) as well as
heightened levels of affective instability [1–3]. An
intense experience of aversive emotions has been linked
to higher psychopathology in trauma survivors [4–14].
To emphasize the emotional consequences of traumatic
experiences, the DSM-5 introduced two new criteria for
PTSD as part of the new symptom cluster D “negative
alterations in cognitions and mood” [15]: “Persistent,
distorted cognitions about the cause or consequences of
the traumatic event(s) that lead the individual to blame
himself/herself or others” as well as “persistent negative
emotional state (e.g., fear, horror, anger, guilt, or
shame)”. These criteria extend the three PTSD symptom
clusters that were previously defined in the DSM-IV-TR
[16] and earlier versions (re-experiencing, avoidance/
emotional numbing, and hyperarousal), as well as the
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central affective symptoms of restricted affect, distress
during confrontation with trauma triggers, and irritabil-
ity/outbursts of anger.
Trauma-focused treatments have shown to be effica-
cious for PTSD [17]. They reduce avoidance of memor-
ies and associated emotions. Research on affective
changes in trauma-focused therapy has focused primarily
on fear and non-specific distress-partly as a consequence
of Foa and Kozak’s influential Emotional Processing
Theory [18]. Within this framework, a pathological “fear
structure” is defined as the central component of anxiety
disorders and PTSD [19]. The framework posits that the
reduction of fear and distress over the course of several
exposure sessions (between-session) leads to reduced
expectations of threat and subsequently to a change in
the fear structure. Consequently, the between-session
changes in self-reported fear and distress were hypothe-
sized to be important process variables.
However, emotional consequences of trauma can differ
widely between patients. In a pilot study by Power and
Fyvie [20], about half of the 75 patients with mixed
trauma types reported fear as the most prevalent emo-
tion since the traumatic event. The other half reported a
primary experience of disgust, sadness or anger that was
associated with longer periods since the onset of psycho-
logical problems. Patients with interpersonal violence
exposure (IPV) in particular reported elevated ratings of
shame, guilt, fear, disgust, and anger in several studies
[1, 2, 21]. Thus, focusing on emotions other than fear
might be particularly relevant in studies on IPV-related
PTSD [22, 23].
Studies showed that fear, shame, guilt, sadness, anger,
and disgust significantly decrease from the start to the
end of trauma-focused therapy [22, 24–28]. To date, a
number of studies have investigated the link between
PTSD symptomatology according to the DSM and fear
or distress experienced within trauma-focused therapy
[26, 29–36]. A recent meta-analysis showed that a
between-session decrease in fear and distress is associ-
ated with a decrease of PTSD symptoms as defined by
the DSM [37]. However, only a few studies have focused
on links between PTSD symptomatology and other
trauma-related emotions in trauma-focused therapy. In
one study on women with IPV-related PTSD, a higher
between-session decrease in sadness and anger was asso-
ciated with remission after exposure therapy [26]. In that
study, remission was defined according to the PTSD
Symptom Scale-Interview (PSS-I) [38], and emotions were
assessed during sessions. Similarly, another study mea-
sured PTSD symptomatology (re-experiencing, avoidance,
and dissociation) as well as trauma-related emotions dur-
ing a repeated imagery rescripting task for women with
sexual assault experience. As a result, a between-session
decrease in disgust was predictive of reduced PTSD
symptomatology during the task but only in women who
showed a significant between-session decrease in fear [39].
In contrast, a study of combat veterans did not find any
statistically significant correlations between sadness, anger,
and guilt as experienced during imaginal flooding sessions
and the number of daily intrusions after therapy [28].
In other studies, emotions were not assessed in
therapy sessions, but were assessed in other settings
independent of therapeutic interventions. In one of these
studies, patients with mixed trauma types received
trauma-focused therapy and rated weekly levels of
trauma-related shame and guilt [40]. Weekly changes in
both emotions were positively correlated with subse-
quent changes in the PTSD Symptom Scale – Self-
Rating (PSS-SR) [38]. Similarly, reductions in guilt from
pre to mid treatment predicted reductions in the
Clinician-Administered PTSD Scale (CAPS) [41] in a
study with trauma-focused therapy for patients with
IPV-related PTSD [24]. A study on psychotherapy for
patients with PTSD related to childhood sexual abuse
(CSA) who were at risk for Human Immunodeficiency
Virus showed conflicting findings [25]: Pre-post-therapy
reductions in shame, but not in guilt, correlated signifi-
cantly with reductions in the Posttraumatic Stress Dis-
order Checklist–Specific (PCL-S) [42]. Overall, empirical
data suggest that the between-session decrease in fear and
distress is a potential proxy for changes in PTSD symp-
tomatology as defined by the DSM-IV and earlier versions.
However, the question of whether other trauma-related
emotions are similarly relevant requires further investiga-
tion. To date, only a few studies [26, 28] have assessed a
wide range of trauma-related emotions rather than only
one or two specific emotions [25, 27, 40].
Another PTSD symptom cluster is avoidance and
emotional numbing [15]. A recent meta-analysis linked
the tendency to avoid painful emotions, thoughts, and
memories (“experiential avoidance”) [43] to the severity
of PTSD symptoms in samples with various trauma
types [44]. “Third wave therapies” such as Acceptance
and Commitment Therapy (ACT) [45] or Dialectical
Behavior Therapy (DBT) [46] stress the importance of
accepting and tolerating aversive emotions. For example,
DBT teaches the concept of “radical acceptance”, which
involves the acceptance of unchangeable emotions,
thoughts, and unchangeable circumstances [46]. Steil
and colleagues [47] combined elements of DBT with
trauma-focused cognitive interventions and exposure
therapy for patients with PTSD after CSA (DBT-PTSD)
[48–51]. Following the DBT concept of radical accept-
ance, DBT-PTSD encourages patients to accept past
traumatic events, painful memories of those events, and
emotions about having experienced such adversities (in-
stead of avoiding, rejecting and fighting). Some empirical
evidence on the importance of acceptance comes from
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ACT for patients with chronic pain where acceptance of
pain mediated the treatment effect on physical function-
ing [52]. To our knowledge, no previous empirical study
has yet examined the pre to post change of radical
acceptance in DBT. Given the central role that radical
acceptance plays in DBT-based treatments, it would be
clinically relevant to test whether this variable is subject
to change.
Research questions
In summary, some empirical evidence has shown that
trauma-related emotions decline between the start and
the end of trauma-focused treatments. In addition,
higher decreases in fear and distress between therapy
sessions were linked to higher decreases in PTSD symp-
tomatology according to the DSM-IV and earlier ver-
sions. However, research about the link between PTSD
symptomatology and trauma-related emotions beyond
fear is limited. It also remains unclear whether radical
acceptance according to DBT definitions changes from
the start to the end of DBT-based trauma-focused ther-
apy. This study investigates the change in trauma-related
emotions and radical acceptance from the start to the
end of DBT-PTSD. We hypothesized that there would
be a decrease in all negative trauma-related emotions
and an increase in radical acceptance over time. Further-
more, the study aims to replicate the well-established
links between distress, fear, and PTSD symptomatology.
Potential links between other trauma-related emotions,
radical acceptance and PTSD symptomatology according
to the CAPS [41] are also explored. The data were col-
lected within a subsample of a randomized controlled
trial (RCT) which tested the efficacy of DBT-PTSD. In
the original study, DBT-PTSD was found to be superior
to a treatment-as-usual waitlist control group (TAU)
with large effect sizes in a self-reported and clinician-
administered PTSD measure. The main results were
published elsewhere [48]. Here, only data from patients
receiving DBT-PTSD was analyzed.
Methods
Sample
Female participants aged 17 to 65 years old with a current
diagnosis of PTSD related to CSA were included in the
RCT [48]. In addition, at least one of the following criteria
had to be met: meeting four or more DSM-IV criteria of
borderline personality disorder (BPD), current eating
disorder, current major depressive disorder, or current
substance abuse. While PTSD in trauma-exposed samples
with a history of CSA is frequently accompanied by co-
morbidities such as substance abuse, alcohol abuse, or
BPD [53], patients with such comorbidities as well as eat-
ing disorders or increased suicide risk are often excluded
from studies [54–57]. To increase the external validity
these comorbidities were included in the original RCT.
Exclusion criteria were: medical contraindications for ex-
posure treatment (e.g., severe cardiovascular disorders;
body mass index <16.5), life-threatening behavior within
4 months prior to study entry, intellectual disability, a life-
time diagnosis of schizophrenia or bipolar I disorder, or a
current diagnosis of substance dependence.
Within the RCT, patients were randomized to receive
either DBT-PTSD or the TAU. In the DBT-PTSD group,
39 patients started the therapy. After the study period,
all patients from the TAU group (n = 39) were offered
DBT-PTSD treatment and 32 of the 39 patients started
the treatment. To increase the sample size, this analysis
included both patients from the original DBT-PTSD trial
arm as well as patients from the TAU group if they re-
ceived DBT-PTSD after the original study period. Only
data collected during the DBT-PTSD treatment were in-
cluded. Ratings of emotions and acceptance were intro-
duced at a later stage of the study period, so that data
on trauma-related emotions would be available for a
subsample. Our analysis required at least two assess-
ments of trauma-related emotions during the start (week
2–4) and end (final two consecutive weeks before dis-
charge) of therapy. These data were available for 28 pa-
tients, and 23 patients completed the diagnostic sessions
at the beginning and end of therapy. Within the final
sample of 23 patients, 15 patients came from the DBT-
PTSD group and 8 patients were originally in the TAU
group and eventually received the active treatment.
Treatment
Participants received between 12 and 14 weeks of a modu-
lar residential treatment at the PTSD unit of the Central
Institute for Mental Health, Mannheim, Germany (CIMH).
The detailed treatment protocol of this study is described
elsewhere [48]. Week one to week four mainly included
psychoeducation of PTSD: teaching of DBT skills and
identification of individual avoidance behavior (e. g.
dissociation, self-harm, and cognitive denial). Patients
received imaginal exposure from week five to week 10.
Between the sessions, patients listened to audio-recordings
of the exposure sessions as a self-administered exposure
exercise. During exposure, DBT interventions (e.g., dis-
traction skills) could be used to ensure awareness of the
present as opposed to dissociative states or flashbacks.
Furthermore, emotion regulation strategies could be
applied to down-regulate overwhelming emotional re-
sponses. In addition, there were cognitive interventions
that focused on guilt and discrimination between the
current and the traumatic situation [58]. In the final
2 weeks, specific interventions aimed at achieving radical
acceptance. Patients received biweekly psychotherapy ses-
sions and took part in several group activities (11 sessions
of 90 min DBT skills training, eight 60 min sessions of
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skills training for self-esteem, 35 sessions of 25 min mind-
fulness training, 11 sessions of 60 min psychoeducation
on PTSD and weekly group interventions on music or art
therapy). The therapy was delivered by clinical psycholo-
gists with additional training in DBT and trauma-focused
therapy. Participants in the TAU-WL group were allowed
to seek any kind of treatment except for DBT-PTSD
within the 6-month study period.
Assessments
Diagnosis of PTSD following CSA and axis I comorbidi-
ties were checked with the Structured Clinical Interview
for DSM-IV Axis I Disorders [59]. BPD symptoms were
diagnosed with the International Personality Disorder
Examination (IPDE) [60]. The outcome measure used in
this study was the CAPS [41]. Ratings referred to the
index event, i.e., the traumatic situation that is currently
causing the highest level of distress. Global psychopath-
ology was assessed with the Symptom Checklist 90-R
(SCL-90-R) to compute the Global Severity Index (GSI)
[61]. The CAPS was assessed before and after DBT-
PTSD treatment. Ratings on trauma-related emotions
were filled out directly before treatment sessions. Origin-
ally, these assessments served as a feedback instrument to
measure the patients’ progress regarding trauma-related
emotionality. It was not designed for study purposes. In
the questionnaire, patients were asked to think of the
index event and then rate their levels of shame, guilt, dis-
tress, disgust, fear, anger, sadness, and radical acceptance
in response to it. The scale ranged from 0 (not at all) to
100 (maximum). Psychoeducation in all trauma-related
emotions and radical acceptance was offered in the skills
groups of the treatment.
Statistical analyses
To test which emotions were predominant at the start
(week 2–4) of the treatment, eight two-sided t-tests with
a Bonferoni corrected Alpha level of α = .006 were com-
puted. Each t-test compared scores for one variable with
the average of all other variables (emotions and accept-
ance). To investigate whether trauma-related emotions
decreased (and acceptance increased) over time, we
tested whether these assessments changed on average
between the start (week 2–4) and the end (final 2 weeks)
of therapy. This was done on a descriptive level and with
multilevel models (MLM). Next, we tested whether
treatment outcome as assessed with the CAPS had an
incremental effect on predicting trauma-related emo-
tions and acceptance. For each treatment phase (start vs.
end), at least two and up to seven assessments of
trauma-related emotions and acceptance per patient
were available (see Fig. 1). The MLM used repeated data
that were nested within patients.
Four models for each emotion and acceptance were
computed. In model 1, we estimated the intra-class cor-
relations (ICCs) for these data without the information
whether the rating was at the start or at the end of the
treatment. This quantifies the amount of observed differ-
ences between patients, and it serves as a baseline model
to test whether adding predictors significantly increases
model fit.
In model 2, we added the treatment phase (0 = start;
week 2–4 vs. 1 = end of treatment, final 2 weeks before
discharge) as a fixed effect on the level of the patient.
According to the DBT-PTSD protocol, these two treat-
ment phases correspond with the pre- and post-exposure
phase. This fixed effect therefore captures the average dif-
ference between treatment phases across all patients.
In models 3 and 4, we tested whether treatment out-
come had an incremental effect on trauma-related emo-
tions and acceptance. Treatment outcome was either
included as a dichotomous (model 3) or as a continuous
predictor (model 4). In model 3, we included whether
the patient responded to the therapy or not; (“response”)
as a dichotomous predictor on the between-patient level.
“Response” was defined as a reduction in CAPS scores
of at least 30 from the start to the end of the treatment
[48, 62]. In model 4, we used the reduction in the CAPS
scores from the start to the end of the treatment as a
continuous predictor on the between-patient level. Both
were added as fixed effects to the model. Patients were
included as a random effect in all models. Further details
on the MLMs can be found in Additional file 1.
To choose the model with the best fit to the data we
used the corrected Akaike information criterion (AICc)
which has been shown to be more appropriate in smaller
samples-especially in models for longitudinal data [63, 64].
Lower values indicate a better fit. We evaluated whether
the inclusion of treatment phase as a predictor increased
model fit relative to a non-trend model when predicting
trauma-related emotions and acceptance (comparison be-
tween model 2 and model 1). We also evaluated whether
including therapy outcome as a predictor had an incre-
mental effect on model fit (comparison between model 3
and model 2 and between model 4 and model 2). Further-
more, R2 was computed to illustrate the fit of the models
to the data. This represents the squared correlation be-
tween the observed values and the predicted values of each
model based on the included fixed effects. The weight of
evidence (W) was computed to illustrate the probability
that a model provides the best fit when compared with the
three other models [63]. W states how likely each model is
the best available approximation of the data compared
to the other available models. For graphs and descrip-
tives we used IBM SPSS Statistics 21; MLM analysis
were done with the R software version 3.1.3 [65],
package lme4 [66].
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Results
Sample characteristics
The average age of the all-female sample was 36.3
(SD = 10.5; range 20 to 52 years). Patients initially had
an average CAPS severity score of 88.1 (SD = 15.2)
which was comparable to the original entire RCT sample
(M = 85.2, SD = 16.38) [48]. The average GSI in our sub-
sample was 1.99 (SD = 0.66) (entire sample: M = 1.95,
SD = 0.62). Patients in our subsample showed an average
decrease in CAPS scores of 32.0 (SD = 25.7). Of the 23
patients, 14 fulfilled the response criterion at the end of
the therapy (reduction of at least 30 points reduction in
the CAPS [42]). For responders, the average decrease in
CAPS scores was 51.8 (SD = 19.2) and 10.8 for non-
responders (SD = 9.6). Within this subsample, 12 pa-
tients (52%) fulfilled a diagnosis of BPD according to the
IPDE compared to 45% in the entire RCT sample. On
average, patients in our subsample fulfilled 4.3 BPD cri-
teria (SD = 2.0) and 4.06 (SD = 1.88) in the entire sam-
ple. In this subsample, patients had an average of 2.78
axis I disorders compared to 3.01 axis I comorbidities
across the entire sample. The most frequent comorbidity
in both samples was major depression (subsample: 83%,
entire sample: 80%). Altogether, 78% of patients in the sub-
sample (86% in the entire sample) received psychotropic
medication-most of them antidepressants (subsample and
whole sample: 70%). A more detailed description of
the entire RCT sample can be found in the main
paper [48].
Data description
Six of the eight t-tests that compared one variable (emo-
tion or acceptance) with the average score of all other
variables at the start of the therapy were significant.
Only the t-tests for fear and sadness were non-
significant. In line with Power’s and Fyvie’s findings [20],
patients did not report one predominant emotion at the
start of the treatment, but showed heightened levels of
different emotions. We illustrated whether a change in
emotions resp. acceptance could be observed between
the start (week 2–4) and the end (final 2 weeks before
discharge) of therapy. Figure 2 shows that all of the
trauma-related emotions decreased over time, whereas
radical acceptance increased. This pattern of change is
in line with our prior expectations.
Multilevel modeling
MLMs for the prediction of each trauma-related emo-
tion and acceptance were computed separately. Next,
the fit of models was compared between model 1 (no
trend), model 2 (inclusion of therapy phase as a pre-
dictor), model 3 (inclusion of therapy phase and re-
sponse as predictors), and model 4 (inclusion of therapy
phase and CAPS change as predictors) based on the
AICc. The model parameters can be found in Table 1.
According to the AICc scores, model 1 showed the
worst fit (highest AICc values) for each trauma-related
emotion and acceptance. Thus, the models including the
time in therapy were superior to the baseline models. The
fixed effects were all in line with our hypotheses (that the
intensity of negative emotions would decrease over time
while acceptance would increase). When adding therapy
response as a dichotomous predictor (model 3), the model
fit increased further for every emotion and acceptance.
When adding therapy response as a dimensional predictor
(model 4), model fit increased only in the case of fear
in comparison to model 2. However, in all cases,
model 3 is the most parsimonous description of the
data (lowest AICc).
Fig. 1 Illustration of data inclusion: Change of distress ratings of a participant. Sessions within weeks 2–4 were used to calculate emotion scores
at the start of the treatment. The end of the treatment comprised the final 2 weeks before admission (weeks 13 and 14). Only sessions marked in
grey were used to estimate the models
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Table 1 Fit statistics for the different models for each emotion and acceptance. Model 3 operationalized therapy outcome as
response (CAPS reduction of at least 30 points from the start to the end of the therapy vs. non-response). Model 4 operationalized
therapy outcome as absolute reduction in CAPS scores from start to end
Model 1 (no trend) Model 2 (linear trend
of therapy phase)
Model 3 (linear trend of
therapy phase and response)
Model 4 (linear trend of
therapy phase and CAPS change)
Guilta,b AICc 1729.90 1527.83 1522.38 1530.22
W 0.00 0.06 0.92 0.02
R2 .26 .26 .27
Shame AICc 2010.35 1992.20 1987.85 1995.67
W 0.00 0.10 0.88 0.02
R2 .05 .05 .05
Distress AICc 1620.93 1564.61 1557.53 1564.99
W 0.00 0.03 0.95 0.02
R2 .12 .16 .16
Fear AICc 1658.39 1586.50 1577.68 1581.16
W 0.00 0.01 0.84 0.15
R2 .12 .19 .21
Anger AICc 1640.97 1590.63 1583.36 1592.28
W 0.00 0.03 0.96 0.01
R2 .03 .09 .03
Sadness AICc 1723.26 1661.58 1657.21 1665.10
W 0.00 0.10 0.88 0.02
R2 .01 .01 .01
Disgust AICc 1711.20 1630.35 1625.92 1633.21
W 0.00 0.10 0.88 0.02
R2 .06 .06 .07
Acceptance AICc 1631.22 1526.32 1521.56 1529.63
W 0.00 0.08 0.90 0.02
R2 .15 .16 .15
Note
aR2: correlation between observed and predicted values of each model
bW: Weight of evidence for model in the context of all other models
Fig. 2 Change in trauma-related emotions and acceptance; Mean ± 1 SE of trauma-related emotions at the start and end of the treatment. In
brackets: Standardized mean of the differences (SMD)
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The results are explained in detail for one emotion to
illustrate the selection decisions. In the case of guilt,
models 1 and 2 receive very low weights of evidence, in-
dicating that adding response as a predictor (model 3)
increases the fit to the data substantially. Model 3 is
likely the most appropriate model compared to all other
models.It has the lowest AICc score (1522.38) and the
highest W (0.92) of all four models. This indicates that
not only the inclusion of the response increases preditive
power (compared to models 1 and 2), but that the inclu-
sion of the dichotomous response provided better fit
than the continuous CAPS score (model 4, W = .02). To
conclude, the overall therapy outcome assessed with the
independent criterion CAPS adds information only when
used as a dichotomous predictor (response vs non-
response)-not when used as a continuous predictor. The
trends described for guilt are found for all variables and
only for fear the dimensional predictor of therapy re-
sponse (model 4) added some predictive value.
Table 2 presents the estimated fixed effects of model 3
for all emotions and acceptance. All estimates for the ef-
fect of treatment phase had expected trends, with de-
creases for emotions and increases of acceptance ratings.
The estimated changes differ widely, from a decrease of
6.20 points in sadness to a 35.41 decrease in guilt.
Similarly, the response in the CAPS correlates with a re-
duction in emotions between 1.01 points (sadness) and
18.85 points (fear). Due to the size of the sample, the
standard errors of the individual effects are rather large
and changes in anger and sadness over time are not
statistically robust because their respective standard
errors would lead to non-significant estimates (size of
estimated coefficient compared to 1.96 x SE). For the as-
sociation with CAPS response, only fear and perhaps
distress can be seen as robust with regard to the signifi-
cance of the individual predictors (see Fig. 3).
In a post hoc analysis, we additionally compared trauma-
related emotions at three different time points: t0 (start of
the treatment), t1 (2 weeks prior to discharge), and t2 (end
of the treatment) via repeated measures t-tests and stan-
dardized means of the differences (SMD). The comparison
between t1 and t2 corresponds with the start and the end
of the acceptance-focused interventions. While guilt
(SMD = −1.12) and shame (SMD = −0.72) declined signifi-
cantly from t0 to t1, non-significant reductions were found
in distress (SMD = −0.45), disgust (SMD = −0.34), sadness
(SMD = −0.13), anger (SMD = −0.14), fear (SMD = −0.38)
and non-significant increases in acceptance (SMD = 0.42).
Non-significant reductions between t1 and t2 were found
in guilt (SMD = −0.59), fear (SMD = −0.54), disgust
(SMD = −0.50), shame (SMD = −0.35), distress
(SMD = −0.34), sadness (SMD = −0.32), and anger
(SMD = −0.03), whereas acceptance (SMD = 0.51) in-
creased non-significantly. Thus, the variables changed in
the expected direction in all treatment phases (start
of treatment, start and end of acceptance-focused
interventions).
Discussion
This study investigated whether trauma-related emo-
tions and radical acceptance changed from the start to
the end of DBT-PTSD. Furthermore, the potential link
between this change and the therapy response according
to the Clinician-Administered PTSD Scale was explored
[41]. Expanding upon previous studies, we not only in-
vestigated the role of fear and distress but also included
other trauma-related emotions and radical acceptance.
Overall, statistically parsimonious descriptions of the
data suggest that patients experienced statistically sig-
nificant reductions in shame, guilt, disgust, distress, and
fear and increases in radical acceptance from the start to
the end of the therapy. The model comparisons based
Table 2 Intercepts and slopes of models 3 estimated with the MLMs using time in therapy and therapy response (response vs
non-response) to predict change in emotions and acceptance over time (fixed effects (standard error); scale: 0–100)a,b
Estimated intercept (SE) Coefficient
Treatment phase (SE)
Coefficient
Response (SE)
Guilt 79.90 (8.71) −35.41 (4.03) −11.05 (10.10)
Shame 80.85 (9.98) −27.28 (9.10) −1.34 (10.39)
Distress 75.20 (5.81) −16.31 (3.83) −12.91 (6.64)
Fear 69.92 (7.31) −16.51 (4.55) −18.85 (8.19)a
Anger 55.79 (9.90) −9.40 (5.67) −19.77 (11.59)
Sadness 55.64 (8.68) −6.20 (6.97) −1.01 (10.57)
Disgust 81.44 (7.73) −16.45 (5.95) −5.50 (9.15)
Acceptance 20.41 (8.91) 22.51 (5.66) 7.42 (10.02)
Note
aThe estimated coefficient for CAPS as a continuous predictor for fear (best fitting modell according to AICc) was −16.54
bTime in therapy was coded as “0” (week 2–4 = start) or “1” (final 2 weeks = end treatment). The response was coded as “0” (CAPS change under 30) or response
(CAPS change at least 30)
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on information criteria suggested that all trauma-related
emotions and radical acceptance could potentially be
correlated with a change in the CAPS according to
DSM-IV. However, inferences on specific emotions
should be made with caution due to the small sample
size and standard errors.
Trauma-related emotions play a crucial role in the
treatment of PTSD [22, 23]. Third wave therapies
emphasize the importance of acceptance-based strategies
to deal with unwanted thoughts, feelings and memories
[45, 46]. DBT-PTSD aims at reducing a broad range of
trauma-related emotions while fostering radical accept-
ance as a functional way to deal with traumatic memor-
ies. Along with previous studies [22, 24–28], this study
found a decrease in a broad range of trauma-related
emotions from the start to the end of trauma-focused
therapy. Furthermore, the results showed that radical ac-
ceptance increased during DBT-PTSD. Future studies
should use larger sample sizes and control group designs
to test whether these changes can be attributed to a
treatment effect. However, these results suggest that
along with PTSD symptoms, a range of emotions and
acceptance are subject to change in DBT-PTSD. While
DBT-PTSD explicitly defines radical acceptance as a
treatment target, other trauma-focused treatment focus
on decreasing avoidance of trauma-related memories,
emotions and thoughts. It should be tested in future
studies whether trauma-related treatment per se is
followed by increases in radical acceptance.
As a next step, the individual emotional profile of pa-
tients with PTSD could support differential indications.
For example, CPT was superiour in decreasing trauma-
related guilt in comparison to Prolonged Exposure [27].
Thus, CPT might be recommended for patients with
heightened levels of trauma-related guilt. A promising
approach could involve monitoring and feedback sys-
tems, which have been established in other areas of
mental health for some time [67, 68]. In such systems,
data are gathered continuously alongside treatment.
These data can identify patients at risk of treatment
failure [69]. Combining predictions from Emotional Pro-
cessing Theory and emerging results such as ours, could
establish assessments to guide treatment decisions re-
garding specific emotion-focused interventions [70]. In
the original RCT on DBT-PTSD, more than 60% of the
patients did not show a remission of PTSD symptoms
3 months after treatment [48]. Tailoring the treatment
for specific trauma-related emotions could be one way
to improve the overall treatment efficacy. While different
studies have shown an association between changes in
distress, fear, and PTSD symptomatology from the start
to the end of trauma-focused treatment, results regard-
ing other trauma-related emotions are mixed. The diver-
ging results might be a consequence of differences in the
operationalization of treatment outcome (dimensional
vs. dichotomous), the context of the assessment (during
exposure sessions or independent of the session), and
trauma types (mixed trauma types, veterans, and IPV).
Another possible explanation is that assessments such as
the CAPS, PCL, PSS-I, or PSS-SR could be more closely
related to fear and distress than to other emotions be-
cause they go back to the conceptualization of PTSD as
an anxiety disorder. In concordance with that, a study
on the contribution of global guilt, guilt cognitions, and
distress on the prediction of PTSD symptomatology sug-
gested that distress might be the strongest predictor
[71]. Therefore, trauma-related shame, guilt, anger, sad-
ness, and disgust could potentially represent pathogno-
monic aspects of PTSD symptomatology that have not
been covered sufficiently by the CAPS. More specifically,
emotions related to the self-concept such as shame,
guilt, and disgust could potentially be a neglected area in
earlier conceptualizations of PTSD [72, 73]. These emo-
tions are related to different psychopathological
Fig. 3 Model coefficients; Estimated coefficients ±1 SE for the effect of therapy response on trauma-related emotions
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symptoms: Suicidal ideation is associated with higher
levels of guilt among military personnel [5] and with
higher levels of sadness, guilt, and shame-proneness in
women with major depression and a history of CSA,
even after controlling for PTSD symptoms and other co-
variates [14]. Thus, trauma-related emotions might be
important variables to assess during trauma-focused
therapy in addition to standard PTSD measures.
Strengths and limitations
The study has several strengths and limitations. One
strength is that the study was performed within the rela-
tively controlled environment of the RCT. The study used
standardized diagnostic intake assessments, and different
treatment phases comprised similar interventions for each
patient due to the manualization of the therapy as well as
intensive training and supervision of the study therapists.
These factors contribute to the higher internal validity of
our results. The small sample size is a clear limitation of
our study and other studies on trauma-related emotions
[26, 28]. However, the fact that we found significant effects
within a limited number of study participants suggests
relatively large effects for at least some of the dimensions.
Therefore, future studies with larger sample sizes and dif-
ferent patient populations are needed when investigating
trauma-related emotions.
Due to the limited sample size and high intercorrelations
between the different emotions and acceptance, mediation
analysis or testing of differential predictive power of individ-
ual emotions was not possible. However, this would be an
important next step requiring larger sample sizes. Another
limitation is that both the CAPS and the questionnaires on
trauma-related emotions and acceptance focused on one
index event. Thus, these measures could overestimate
symptom improvement. It remains an open question
whether PTSD symptomatology, trauma-related emotions
and acceptance change only with regards to the index event,
or whether this effect generalizes to other traumatic events.
Furthermore, each emotion was assessed with a single
item to reduce the burden on the respondents, but this
might limit the findings’ construct validity. The repeated
short assessments across the course of the therapy still
enabled reliable differentiation between patients as is
evident in the ICCs. For the start of the therapy, ICCs in
the step two models varied between 0.63 and 0.89 except
for shame that had an ICC of 0.14. For the end phase of
the treatment, ICCs ranged from 0.63 to 0.90. However,
future studies should focus on the assessment of a few
trauma-related emotions assessed via several items per
emotion.
At first glance, our analytic strategy of using model-
based averages of several assessments at the start and
end of the therapy might seem limited. Nevertheless,
as Fig. 1 shows, it is far from clear what kind of
change should be assumed (when using growth
models, for example [74]) or how to deal with the
slightly different lengths of treatment in a fixed as-
sessment mixed model analysis [75]. The chosen ap-
proach uses the individually defined treatment phases
to derive a meaningful aggregate estimate of the treat-
ment effect (Fig. 1). This increases the amount of
data used in comparison to a pre-post repeated meas-
urement ANOVA, and the use of all available data
points in a MLM increases the reliability of start- and
end-averages. Furthermore, by relying on differences
between treatment phases this approach also uses a
definition of change that stresses the importance of de-
tecting differences between stretches of time, i.e., stable
levels, instead of only single assessments [74, 76]. Fi-
nally, this study assessed only trauma-related emotions
before therapy sessions. Future studies could increase
the generalizability of the findings via ecological mo-
mentary assessments [77].
Conclusion
This study is the first to our knowledge that has investi-
gated changes in specific trauma-related emotions and
radical acceptance within treatment for PTSD after CSA.
This cohort showed a significant decline in trauma-
related shame, guilt, disgust, distress, and fear. Due to
the lack of a control group, it is unclear whether treat-
ment induced these changes. Patients who showed a
treatment response according to the CAPS had a stron-
ger decrease in fear across both time points (start and
end). The therapy response was related to decreases in
all other trauma-related emotions and increases in ac-
ceptance, but this relationship did not reach statistical
significance in most of the measures due to the small
sample size and high standard errors. In conclusion, fu-
ture studies with larger sample sizes are needed to assess
the change in trauma-related emotions during trauma-
focused therapy in addition to standard measures of
PTSD symptomatology. We suggest testing and build-
ing feedback systems on trauma-related emotions.
They could be used for the differential indication of
emotion-specific interventions. Radical acceptance is
an important yet rarely investigated variable in DBT-
rooted exposure therapy for PTSD that increased from
the start to the end of DBT-PTSD.
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